Solutions

Pipeline and Launch Strategy

The road to pharmaceutical commercialization has grown longer and tougher to navigate, and a robust product pipeline is no assurance of success.

ZS is here to help successfully guide your company from disease area and pipeline strategy through product development and launch. We’ll work with you to develop a customized road map that will improve drug development and commercialization decision-making and efficacy to help ensure your business’s downstream success.

How Good Market Access Strategies Boost New Product Launches

>READ THE ZS INTERVIEW

ZS Oncology Watchdog Report: Biosimilars in Therapeutic Oncology

>DOWNLOAD THE REPORT

The ZS Approach

ZS is a global consulting firm with nearly 5,000 strategy, analytics and technology experts. We’ve worked with pharmaceutical clients for more than 30 years, and while we apply that experience to each new project, we take the time to learn your organization’s unique questions and challenges, and to build customized solutions. Then we’ll work with you to develop a strategy and to execute it from early commercialization through product launch.

Disease Area Strategy

Our disease area strategy framework provides a structured approach to pipeline strategy development and implementation. We’ll help you determine which therapeutic areas to pursue by first uncovering the opportunities that exist and align them with your current company strategy. We’ll help you make the most of your in-house assets as well as external assets to build a long-term strategy to “win” a disease area and build a strong product portfolio.

Product Development Strategy

Our experts will partner with you to determine which product indications to develop and in what order, considering each indication’s feasibility, how to gather and provide evidence for an indication’s value story, and how quickly the product could proceed to trial. We’ll help you ensure that the products you launch achieve maximum potential.

Launch Planning and Readiness

Once your product strategies are developed, we’ll guide you through the entire launch process. We’ll work with you to ensure that your organization is prepared, has visibility into strategy and specific tactics, and is properly aligned with functional accountability so that nothing falls through the cracks.

Throughout the strategy, planning and launch process, we’ll leverage a set of trusted solutions, including:

  • Customer journey: Determine the current customer landscape, how decisions are made and who makes them
  • Opportunity assessment: Uncover available product opportunities and how to take advantage of them
  • Market access and pricing: Understand the information that payers need, including pricing options and expected level of access
  • Forecasting: Calculate the potential profitability of the product and understand where opportunities lie, along with the upsides and risks, and how to influence the forecast
  • Segmentation: Outline and prioritize prescribers and patients, and discover how they think and make decisions for more effective customer outreach
  • Core benefits and positioning: Identify the core benefits of your product, the value propositions that will appeal to each stakeholder, and how to best position your product in the market

Hands-On Pipeline and Launch Strategy

Our goal is to help you improve the efficiency of your drug development and commercialization processes—and improve your business’s profitability. We combine strategy, insights, technology and deep expertise to help solve your organization’s problems. We take a hands-on, collaborative approach to each project, partnering with you to develop effective plans and then working side by side to execute them.

How Good Market Access Strategies Boost New Product Launches

>READ THE ZS INTERVIEW

ZS Oncology Watchdog Report: Biosimilars in Therapeutic Oncology

>DOWNLOAD THE REPORT